Skip to navigation Skip to content

News

Share

Too soon to make recommendation for COVID-19 vaccine boosters for those living with MS

July 9, 2021

In response to Pfizer’s application for a third dose or booster of its COVID-19 vaccine, the National Multiple Sclerosis Society’s COVID-19 Vaccine Advisory Committee will review the data and recommendations from the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) as soon as they are available and provide guidance to the MS community. 

On July 8, Pfizer issued a press release announcing they were applying to the FDA for authorization of a third dose or booster dose of their COVID-19 vaccine. The FDA and CDC issued a joint statement on July 9 stating:

“People who are fully vaccinated are protected from severe disease and death, including from the variants currently circulating in the country such as Delta. People who are not vaccinated remain at risk. Virtually all COVID-19 hospitalizations and deaths are among those who are unvaccinated. We encourage Americans who have not yet been vaccinated to get vaccinated as soon as possible to protect themselves and their community.

Americans who have been fully vaccinated do not need a booster shot at this time. FDA, CDC, and NIH are engaged in a science-based, rigorous process to consider whether or when a booster might be necessary… We are prepared for booster doses if and when the science demonstrates that they are needed.”

The National MS Society provides information about COVID-19 and MS in its COVID-19 Resource Center.

En Español:

Es demasiado pronto para hacer recomendación sobre las dosis de refuerzo de la vacuna contra el COVID-19 para las personas con esclerosis múltiple

9 de julio de 2021

En respuesta a la solicitud por Pfizer de una tercera dosis o refuerzo a su vacuna contra el COVID-19, el Comité Asesor de Vacunación contra el COVID-19 de la Sociedad Nacional de Esclerosis Múltiple revisará los datos y las recomendaciones de la Dirección de Alimentos y Medicamentos (Food and Drug Administration o FDA) y el Centro de Control y Prevención de Enfermedades (Centers for Disease Control and Prevention o CDC) tan pronto estén disponibles y hará recomendaciones a la comunidad de esclerosis múltiple. 

El 8 de julio, Pfizer sacó un comunicado de prensa en el que anunció que está solicitando autorización por la FDA de una tercera dosis o refuerzo para su vacuna contra el COVID-19. La FDA y el CDC emitieron una declaración conjunta el 9 de julio:

“Las personas que están totalmente vacunadas están protegidas de enfermedad grave y muerte, incluso de las variantes que circulan actualmente en el país, como la Delta. Las personas que no están vacunadas siguen en peligro de ello. Prácticamente todas las hospitalizaciones y muertes por COVID-19 se produjeron entre los no vacunados. Exhortamos a los estadounidenses que no se han vacunado a que lo hagan lo antes posible para protegerse a sí mismos y su comunidad.

Los estadounidenses que están totalmente vacunados no necesitan un refuerzo en este momento. La FDA, el CDC y el NIH participan en un proceso riguroso y basado en los conocimientos científicos para considerar si una dosis de refuerzo es necesaria y cuándo… Estamos preparados para dosis de refuerzo si y cuando se demuestre científicamente que son necesarias”.

La Sociedad Nacional de Esclerosis Múltiple proporciona información sobre el COVID-19 y la esclerosis múltiple en su Centro de Recursos sobre el COVID-19.

About Multiple Sclerosis

Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system. There is currently no cure for MS. Symptoms vary from person to person and range from numbness and tingling, to mobility challenges, blindness and paralysis. An estimated 1 million people live with MS in the United States. Most people are diagnosed between the ages of 20 and 50, and it affects women three times more than men.

About the National Multiple Sclerosis Society

The National MS Society, founded in 1946, funds cutting-edge research, drives change through advocacy, and provides programs and services to help people affected by MS live their best lives. Connect to learn more and get involved: nationalMSsociety.org, Facebook, Twitter, Instagram, YouTube or 1-800-344-4867.

Share


© 2021 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.